AKE-1018

N/A

Report date: 2023/06/20 09:10:07
NME

Base Information

Drug NameAKE-1018
Drug Alias NameAKE-1018AKE 1018
ClassificationSmall molecules
Mechanisms of ActionHyperpolarization-activated cyclic nucleotide-gated channel blockers
TargetsHyperpolarization-activated cyclic nucleotide-gated channel
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia UniversityWeill Cornell Medicine
China Registration ClassN/A

Develop Information

Active CompaniesWeill Cornell MedicineColumbia University
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A